{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:45:39Z","timestamp":1790642739732,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Echocardiogr"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about 0.2\u20130.5% of the population. While most of the patients with HCM have a relatively good prognosis, some are at increased risk of adverse events. Identifying such patients at risk is important for optimal treatment and follow-up. While clinical and electrocardiographic information plays an important role, echocardiography remains the cornerstone in assessing patients with HCM. In this review, we discuss the role of echocardiography in diagnosing HCM, the key features that differentiate HCM from other diseases and the use of echocardiography for risk stratification in this setting (risk of sudden cardiac death, heart failure, atrial fibrillation and stroke). The use of modern echocardiographic techniques (deformation imaging, 3D echocardiography) refines the diagnosis and prognostic assessment of patients with HCM. The echocardiographic data need to be integrated with clinical data and other information, including cardiac magnetic resonance, especially in challenging cases or when there is incomplete information, for the optimal management of these patients.\n<\/jats:p>","DOI":"10.1007\/s12574-020-00467-9","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T14:02:36Z","timestamp":1587045756000},"page":"137-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"18","author":[{"given":"Leonard","family":"Mande\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ro\u015fca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ciuperc\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"issue":"39","key":"467_CR1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliot","year":"2014","unstructured":"Elliot PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733\u201379.","journal-title":"Eur Heart J"},{"issue":"4","key":"467_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin J, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults. Circulation. 1995;92(4):785\u20139.","journal-title":"Circulation"},{"issue":"12","key":"467_CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9149(87)80107-8","volume":"93","author":"Y Hada","year":"1987","unstructured":"Hada Y, Sakamoto T, Amano K, et al. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. Am J Cardiol. 1987;93(12):183\u20134.","journal-title":"Am J Cardiol"},{"issue":"12","key":"467_CR4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2004.03.007","volume":"93","author":"BJ Maron","year":"2004","unstructured":"Maron BJ, Spirito P, Roman MJ, et al. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol. 2004;93(12):1510\u20134.","journal-title":"Am J Cardiol"},{"issue":"25","key":"467_CR5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(25):1249\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"467_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","volume":"104","author":"J Seidman","year":"2001","unstructured":"Seidman J, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557\u201367.","journal-title":"Cell"},{"key":"467_CR7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"D MacArthur","year":"2014","unstructured":"MacArthur D, Manolio T, Dimmock D, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508:469\u201376.","journal-title":"Nature"},{"key":"467_CR8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjcard.2010.10.022","volume":"107","author":"BJ Maron","year":"2011","unstructured":"Maron BJ, Yeates L, Semsarian C. Clinical challenges of genotype positive (+)-phenotype negative (\u2212) family members in hypertrophic cardiomyopathy. Am J Cardiol. 2011;107:604\u20138.","journal-title":"Am J Cardiol"},{"key":"467_CR9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","volume":"152","author":"B Gray","year":"2011","unstructured":"Gray B, Ingles J, Semsarian C. Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. Int J Cardiol. 2011;152:258\u20139.","journal-title":"Int J Cardiol"},{"issue":"5","key":"467_CR10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0735-1097(03)00855-6","volume":"42","author":"BJ Maron","year":"2003","unstructured":"Maron BJ, Casey SA, Hauser RG, et al. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003;42(5):882\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"467_CR11","first-page":"A13294","volume":"128","author":"EJ Rowin","year":"2013","unstructured":"Rowin EJ, Maron MS, Casey SA, et al. Evidence for reduced mortality in an adult cohort with hypertrophic cardiomyopathy. Circulation. 2013;128:A13294 (abstr).","journal-title":"Circulation"},{"key":"467_CR12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(73)92730-X","volume":"II","author":"T Hadarson","year":"1973","unstructured":"Hadarson T, De la Calzada CS, Curier R, et al. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973;II:1462\u20137.","journal-title":"Lancet"},{"key":"467_CR13","first-page":"179","volume":"35","author":"PM Shah","year":"1974","unstructured":"Shah PM, Adelman AG, Wigle ED, et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res. 1974;35:179\u201395.","journal-title":"Circ Res"},{"key":"467_CR14","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","volume":"113","author":"P Spirito","year":"2014","unstructured":"Spirito P, Autore C, Formisano F, et al. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors. Am J Cardiol. 2014;113:1550\u20135.","journal-title":"Am J Cardiol"},{"issue":"5","key":"467_CR15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","volume":"127","author":"BJ Maron","year":"2012","unstructured":"Maron BJ, Rowin EJ, Casey SA, et al. Risk stratification and outcome of patients with hypertrophic cardiomyopathy \u2265 60 years of age. Circulation. 2012;127(5):585\u201393.","journal-title":"Circulation"},{"issue":"25","key":"467_CR16","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","volume":"136","author":"EJ Rowin","year":"2017","unstructured":"Rowin EJ, Hausvater A, Link MS, et al. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy. Circulation. 2017;136(25):2420\u201336.","journal-title":"Circulation"},{"key":"467_CR17","first-page":"783","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2011;124:783\u2013831.","journal-title":"Circulation"},{"issue":"8","key":"467_CR18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ejechocard\/jep157","volume":"10","author":"LK Williams","year":"2009","unstructured":"Williams LK, Frenneaux MP, Steeds RP. Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur J Echocardiogr. 2009;10(8):9\u201314.","journal-title":"Eur J Echocardiogr"},{"issue":"3","key":"467_CR19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","volume":"16","author":"N Cardim","year":"2015","unstructured":"Cardim N, Galderisi M, Edvardsen T, et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging. 2015;16(3):280.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"467_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","volume":"54","author":"JM Bos","year":"2009","unstructured":"Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54:201\u201311.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"467_CR21","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.echo.2015.07.015","volume":"28","author":"M Rosca","year":"2015","unstructured":"Rosca M, Calin A, Beladan CC, et al. Right ventricular remodeling, its correlates, and its clinical impact in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2015;28(11):1329\u201338.","journal-title":"J Am Soc Echocardiogr"},{"key":"467_CR22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"467_CR23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","volume":"111","author":"P Hoigne","year":"2006","unstructured":"Hoigne P, Attenhofer Jost CH, Duru F, et al. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. Int J Cardiol. 2006;111:413\u201322.","journal-title":"Int J Cardiol"},{"key":"467_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9149(80)90232-5","volume":"45","author":"BJ Maron","year":"1980","unstructured":"Maron BJ, Epstein SE. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol. 1980;45:141\u201354.","journal-title":"Am J Cardiol"},{"issue":"2","key":"467_CR25","first-page":"279","volume":"2","author":"J Sun","year":"2017","unstructured":"Sun J, Yang X, Wang S. The role of echocardiography in hypertrophic cardiomyopathy. CIVA. 2017;2(2):279\u201386.","journal-title":"CIVA"},{"issue":"8","key":"467_CR26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2017.06.046","volume":"70","author":"TM Stokke","year":"2017","unstructured":"Stokke TM, Hasselberg NE, Smedsrud MK, et al. Geometry as a confounder when assessing ventricular systolic function: comparison between ejection fraction and strain. J Am Coll Cardiol. 2017;70(8):942\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"467_CR27","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000124723.16433.31","volume":"109","author":"CJ McMahon","year":"2004","unstructured":"McMahon CJ, Nagueh SF, Pignatelli RH, et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation. 2004;109(14):1756\u201362.","journal-title":"Circulation"},{"key":"467_CR28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ejechocard\/jen049","volume":"9","author":"F Bayrak","year":"2008","unstructured":"Bayrak F, Kahveci G, Mutlu B, et al. Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy. Eur J Echocardiogr. 2008;9:278\u201383.","journal-title":"Eur J Echocardiogr"},{"key":"467_CR29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.CIR.0000084500.72232.8D","volume":"108","author":"SF Nagueh","year":"2003","unstructured":"Nagueh SF, McFalls J, Meyer D, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003;108:395\u20138.","journal-title":"Circulation"},{"issue":"4","key":"467_CR30","first-page":"560","volume":"9","author":"M Reddy","year":"2008","unstructured":"Reddy M, Thatai D, Bernal J, et al. Apical hypertrophic cardiomyopathy: potential utility of strain imaging. Eur J Echocardiogr. 2008;9(4):560\u20132.","journal-title":"Eur J Echocardiogr"},{"key":"467_CR31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0002-9149(98)00648-1","volume":"82","author":"S Severino","year":"1998","unstructured":"Severino S, Caso P, Galderisi M, et al. Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy. Am J Cardiol. 1998;82:1394\u20138.","journal-title":"Am J Cardiol"},{"key":"467_CR32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2006.05.013","volume":"98","author":"S Nistri","year":"2006","unstructured":"Nistri S, Olivotto I, Betocchi S, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006;98:960\u20135.","journal-title":"Am J Cardiol"},{"key":"467_CR33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(96)00315-4","volume":"28","author":"R Nishimura","year":"1996","unstructured":"Nishimura R, Appleton C, Redfield MM, et al. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol. 1996;28:1226\u2013333.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"467_CR34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0002-9149(00)00855-9","volume":"86","author":"E Schwammenthal","year":"2000","unstructured":"Schwammenthal E, Popescu BA, Popescu AC, et al. Noninvasive assessment of left ventricular end-diastolic pressure by the response of the transmitral a-wave velocity to a standardized Valsalva maneuver. Am J Cardiol. 2000;86(2):169\u201374.","journal-title":"Am J Cardiol"},{"issue":"2","key":"467_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","volume":"10","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10(2):165\u201393.","journal-title":"Eur J Echocardiogr"},{"key":"467_CR36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","volume":"348","author":"MS Maron","year":"2003","unstructured":"Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295\u2013303.","journal-title":"N Engl J Med"},{"key":"467_CR37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.97.5.461","volume":"97","author":"AM Kizilbash","year":"1998","unstructured":"Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation. 1998;97:461\u20136.","journal-title":"Circulation"},{"key":"467_CR38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.CIR.91.4.1189","volume":"91","author":"RA Levine","year":"1995","unstructured":"Levine RA, Vlahakes GJ, Lefebvre X, et al. Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction. Circulation. 1995;91:1189\u201395.","journal-title":"Circulation"},{"issue":"11","key":"467_CR39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcmg.2017.07.016","volume":"10","author":"EJ Rowin","year":"2017","unstructured":"Rowin EJ, Maron BJ, Olivotto I, et al. Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(11):1274\u201386.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"467_CR40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s13244-018-0656-8","volume":"9","author":"R Soler","year":"2018","unstructured":"Soler R, Mendez C, Rodriguez E, et al. Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings. Insights Imaging. 2018;9(6):1007\u2013200.","journal-title":"Insights Imaging"},{"issue":"6","key":"467_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/CRD.0000000000000076","volume":"23","author":"GK Efthimiadis","year":"2015","unstructured":"Efthimiadis GK, Pagourelias ED, Hadjimiltiades S, et al. Feasibility and significance of preclinical diagnosis in hypertrophic cardiomyopathy. Cardiol Rev. 2015;23(6):297\u2013302.","journal-title":"Cardiol Rev"},{"issue":"5","key":"467_CR42","doi-asserted-by":"crossref","first-page":"e36115","DOI":"10.1371\/journal.pone.0036115","volume":"7","author":"KH Yiu","year":"2012","unstructured":"Yiu KH, Atsma DE, Delgado V, et al. Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers. PLoS ONE. 2012;7(5):e36115.","journal-title":"PLoS ONE"},{"key":"467_CR43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjcard.2008.04.033","volume":"102","author":"S Caselli","year":"2008","unstructured":"Caselli S, Pelliccia A, Maron MS, et al. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography. Am J Cardiol. 2008;102:616\u201320.","journal-title":"Am J Cardiol"},{"key":"467_CR44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1540-8175.2005.40073.x","volume":"22","author":"A D'Andrea","year":"2005","unstructured":"D'Andrea A, Caso P, Severino S, et al. Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy. Echocardiogr J Card. 2005;22:571\u20138.","journal-title":"Echocardiogr J Card"},{"issue":"24","key":"467_CR45","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","volume":"342","author":"P Spirito","year":"2000","unstructured":"Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342(24):1778\u2013855.","journal-title":"N Engl J Med"},{"issue":"5","key":"467_CR46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/HCO.0000000000000199","volume":"30","author":"BA Popescu","year":"2015","unstructured":"Popescu BA, Rosca M, Schwammenthal E. Dynamic obstruction in hypertrophic cardiomyopathy. Curr Opin Card. 2015;30(5):468\u201374.","journal-title":"Curr Opin Card"},{"issue":"7","key":"467_CR47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","volume":"69","author":"EJ Rowin","year":"2017","unstructured":"Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. J Am Coll Cardiol. 2017;69(7):761\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"467_CR48","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","volume":"12","author":"A Tower-Rader","year":"2019","unstructured":"Tower-Rader A, Mohananey D, To A, et al. Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy. A systematic review of existing literature. JACC Cardiovasc Imaging. 2019;12(10):1930\u201342.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"467_CR49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ehjci\/jew005","volume":"17","author":"TF Haland","year":"2016","unstructured":"Haland TF, Almaas VM, Hasselberg NE, et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17(6):613\u201321.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"9","key":"467_CR50","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.echo.2011.05.009","volume":"24","author":"H Kitaoka","year":"2011","unstructured":"Kitaoka H, Kubo T, Okawa M, et al. Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2011;24(9):1020\u20135.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"467_CR51","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.01.023","volume":"67","author":"MS Maron","year":"2016","unstructured":"Maron MS, Rowin EJ, Olivotto I, et al. Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016;67(12):1399\u2013409.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"467_CR52","first-page":"3","volume":"15","author":"E Picano","year":"2017","unstructured":"Picano E, Ciampi Q, Citro R, et al. Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease. Echocardiogr J Card. 2017;15(1):3.","journal-title":"Echocardiogr J Card"},{"issue":"10","key":"467_CR53","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.echo.2010.07.016","volume":"23","author":"M Rosca","year":"2010","unstructured":"Rosca M, Popescu BA, Beladan CC, et al. Left atrial dysfunction as a correlate of heart failure. J Am Soc Echocardiogr. 2010;23(10):1090\u20138.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"467_CR54","doi-asserted-by":"crossref","first-page":"e004052","DOI":"10.1161\/CIRCEP.116.004052","volume":"10","author":"P Debonnaire","year":"2017","unstructured":"Debonnaire P, Joyce E, Hiemstra Y, et al. Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation. Circ Arrhythm Electrophysiol. 2017;10(2):e004052.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"467_CR55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","volume":"39","author":"BJ Maron","year":"2002","unstructured":"Maron BJ, Olivotto I, Bellone P, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(2):301\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"467_CR56","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.echo.2012.12.015","volume":"26","author":"SA Chang","year":"2013","unstructured":"Chang SA, Kim HK, Lee SC, et al. Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image. J Am Soc Echocardiogr. 2013;26:436\u201342.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1190","key":"467_CR57","first-page":"e1","volume":"19","author":"C De Gregorio","year":"2006","unstructured":"De Gregorio C, Recupero A, Grimaldi P, et al. Can transthoracic live 3-dimensional echocardiography improve the recognition of midventricular obliteration in hypertrophic obstructive cardiomyopathy? J Am Soc Echocardiogr. 2006;19(1190):e1\u2013e4.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"467_CR58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21037\/cdt.2017.06.01","volume":"8","author":"D Muraru","year":"2018","unstructured":"Muraru D, Niero A, Rodriguez-Zanella H, et al. Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovasc Diagn Ther. 2018;8(1):101.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"18","key":"467_CR59","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/eurheartj\/ehr140","volume":"32","author":"M Papadakis","year":"2011","unstructured":"Papadakis M, Carre F, Kervio G, et al. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African\/Afro-Caribbean origin. Eur Heart J. 2011;32(18):2304\u201313.","journal-title":"Eur Heart J"},{"key":"467_CR60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9149(01)01585-5","volume":"88","author":"D Vinereanu","year":"2011","unstructured":"Vinereanu D, Florescu N, Schulthorpe N, et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol. 2011;88:53\u20138.","journal-title":"Am J Cardiol"},{"key":"467_CR61","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/oxfordjournals.eurheartj.a061411","volume":"41","author":"YL Doi","year":"1983","unstructured":"Doi YL, McKenna WJ, Oakley CM, et al. \u2018Pseudo\u2019 systolic anterior motion in patients with hypertensive heart disease. Eur Heart J. 1983;41:838\u201345.","journal-title":"Eur Heart J"},{"issue":"25","key":"467_CR62","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1161\/01.CIR.0000150334.69355.00","volume":"110","author":"T Kato","year":"2014","unstructured":"Kato T, Noda A, Izawa H, et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Criculation. 2014;110(25):3808\u201314.","journal-title":"Criculation"},{"issue":"1","key":"467_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12947-019-0151-5","volume":"17","author":"W Serra","year":"2019","unstructured":"Serra W, Marziliano N. Role of cardiac imaging in Anderson\u2013Fabry cardiomyopathy. J Cardiovasc Ultrasound. 2019;17(1):1.","journal-title":"J Cardiovasc Ultrasound"}],"container-title":["Journal of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-020-00467-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12574-020-00467-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-020-00467-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T23:11:20Z","timestamp":1618528280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12574-020-00467-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1007\/s12574-020-00467-9","relation":{},"ISSN":["1349-0222","1880-344X"],"issn-type":[{"value":"1349-0222","type":"print"},{"value":"1880-344X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mandes Leonard, Rosca Monica and Ciuperca Daniela declare that they have no conflict of interest. Popescu Bogdan Alexandru has received research support and lecture honoraria from General Electric Healthcare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}